The ERAP1 gene gives your cells instructions for trimming small protein pieces so the immune system can check what is happening inside the body. This gene helps your body present those pieces to immune cells and may also influence inflammation. If the gene does not work as expected, immune signaling can become less balanced, and some variants are linked to a higher chance of conditions such as ankylosing spondylitis and psoriasis. ERAP1 is mainly discussed in medical and genetics settings rather than popular culture.
What is a gene?
A gene is a section of DNA that carries information your cells use to make molecules or regulate processes in the body. Some genes provide the instructions for making proteins, the working parts of cells. Others mainly help determine when certain processes occur, where they occur, and how strongly they operate. Together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. If you want to explore this subject in greater depth, you can learn more in the LearnHub.
Overview
ERAP1Gene function
What if the gene works
Inside cells, the ERAP1 gene helps trim protein pieces so they fit onto immune display molecules. This helps the immune system recognize infected or abnormal cells.
Risk
What if the gene does not work
Changes in the ERAP1 gene can range from mild to more severe and may change how well cells trim protein fragments before showing them to the immune system. This can alter which fragments are shown and how immune cells respond.
Treatment
What does that mean for your treatment
No ERAP1-specific treatment or drug selection approach is currently established in clinical guidelines for people with pathogenic or loss-of-function variants in the ERAP1 gene. The ERAP1 gene is being studied as a possible drug target and biomarker in immune-related conditions and in cancer immunotherapy research.
Conditions associated with ERAP1
Gene function
What if the gene works
Inside many cells, the ERAP1 gene helps prepare tiny protein pieces for display to the immune system. This quiet housekeeping step lets cells show what is happening inside them in a controlled, readable way. Understanding how the ERAP1 gene works can make it easier to see how your body carries out everyday immune surveillance.
The ERAP1 gene shortens small protein pieces to a size that fits the cell’s display system. This careful trimming helps cells present clean, usable pieces instead of fragments that are too long.
These trimmed pieces are loaded onto HLA class I proteins, which are cell surface proteins that show protein pieces to immune cells. This step supports routine immune checking throughout the body.
ERAP1 helps shape which prepared pieces are most suitable for display. By influencing that set of pieces, it fine tunes day to day immune surveillance.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help explain normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ERAP1 gene can change the shape, stability, or activity of its protein, altering how protein fragments are trimmed inside cells. In plain terms, this is how ERAP1 gene variants affect protein function at the cellular level. Some variants have mild effects and only partly change trimming, while more severe variants can greatly reduce activity, disrupt folding, or change which fragments are shown to the immune system.
How variants are linked to conditions
Research most consistently shows that ERAP1 gene variants are linked to ankylosing spondylitis, also called axial spondyloarthritis, especially in people who also carry HLA-B27. Studies have also associated some ERAP1 variants with psoriasis and Behçet disease. These findings describe changes in risk rather than a diagnosis, so many people with an ERAP1 change never develop these conditions.
A variant is not necessarily a diagnosis
Gene variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural variation among people. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors contribute. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
Changes in the ERAP1 gene usually affect susceptibility rather than guarantee illness. Risk can be higher when an ERAP1 variant is inherited along with certain immune-system gene types, especially HLA-B27, and other genes and environmental factors also play a part. There is not enough evidence to say that specific lifestyle changes directly lower ERAP1-related risk.
Inheritance of ERAP1 variants
For people looking into how variants of the ERAP1 gene are inherited, there is no broadly confirmed single-gene inheritance pattern tied to a specific ERAP1-related condition. Changes in the ERAP1 gene are most often discussed as risk-influencing factors that can run in families along with many other genes, rather than following a clear autosomal dominant or autosomal recessive pattern. The ERAP1 gene is located on chromosome 5, which is one of the autosomes, so you inherit one copy from each parent.
What does my ERAP1 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific ERAP1-related condition in the way seen with single-gene conditions. ERAP1 changes are more often discussed as factors that may slightly affect risk, so what a result means for family members depends on the exact finding and the wider health picture.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for ERAP1 variants usually uses a blood or saliva sample. A lab reads the DNA code in the ERAP1 gene and compares it with the usual sequence to look for variants. Results may show a benign change, a variant of uncertain significance, or a variant linked to a higher chance of some immune conditions.
When should I consider getting a genetic test?
There isn't yet a broadly established, ERAP1-specific clinical reason for testing. Decisions about genetic testing are usually based on your symptoms, diagnosis, and family history, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that helps one person may work less well for another, or may cause more side effects, because the body can absorb, break down, transport, or respond to the same drug in different ways. These differences are common and are one reason medication response is not always the same from person to person. Genetics is only one part of the picture, and age, other health conditions, and other medicines also play a role.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support more informed and personalized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the ERAP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general questions about symptoms, treatment, or side effects are best discussed with your doctor. Research on ERAP1 has focused more on immune-related conditions than on clearly proven differences in how medicines work.
History
ERAP1 entered medical genetics in the early 2000s, when researchers identified it as a gene involved in shaping protein fragments for immune recognition. It was first studied in basic immunology, then drew wider attention as links emerged between ERAP1 variants and inflammatory conditions such as ankylosing spondylitis. From these first observations, research expanded steadily. Scientists also found that ERAP1 often matters most in combination with certain HLA genes, which helped shift thinking toward gene to gene interactions in immune related disease. Over time, descriptions became more precise, and ERAP1 became part of a broader story about how inherited differences can influence immune system signaling.